Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10005833
Methods of treating inflammation associated airway diseases and viral infections
granted -
US 10004687
Liposomal curcumin for treatment of diseases
granted -
US 9993537
Methods and compositions related to Th-1 dendritic cells
granted -
US 9986723
Screen and use of therapeutics for pancreatic ductal adenocarcinoma
granted -
US 9987363
Materials with water-triggered drug-release properties for localized therapeutics
granted -
US 9980956
Methods and therapeutic combinations for treating tumors
granted -
US 9982265
Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury
granted -
US 9980936
BH4 antagonists and methods related thereto
granted -
US 9977033
Methods for assessing cancer recurrence
granted -
US 9975959
Administration of kynurenine depleting enzymes for tumor therapy
granted -
US 9974850
Immunogenic compositions and uses thereof
granted -
US 9962368
Pro-neurogenic compounds
granted -
US 9956172
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
granted -
US 9937256
Hydrogels for delivery of therapeutic compounds
granted -
US 9937156
Modulation of MRTF-A activity in pathologic fibrosis and wound healing
granted -
US 9932564
Recombinant isfahan viral vectors
granted -
US 9926380
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
granted -
US 9925180
Compounds and anti-tumor NQO1 substrates
granted -
US 9918959
TLR-independent small molecule adjuvants
granted -
US 9918968
Rapamycin analogs targeting proteasome function in the treatment of cancer
granted -
US 9921223
Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
granted -
US 9914775
Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels
granted -
US 9913820
Antimicrobial compositions comprising glyceryl nitrates
granted -
US 9907820
Polyclonal gamma delta T cells for immunotherapy
granted